The global Vaginitis Diagnostics market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
Vaginitis diagnostics refer to the methods and procedures used by healthcare providers to diagnose vaginitis, which is the inflammation or infection of the vagina. Diagnosing vaginitis is essential to identify the underlying cause and provide appropriate treatment.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Vaginitis Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Vaginitis Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaginitis Diagnostics. This report contains market size and forecasts of Vaginitis Diagnostics in global, including the following market information:
Global Vaginitis Diagnostics market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Vaginitis Diagnostics companies in 2024 (%)
Total Market by Segment:
Global Vaginitis Diagnostics market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Vaginitis Diagnostics market segment percentages, by Type, 2024 (%)
Nucleic Acid Amplification Assays
DNA Probe
Clinical Test
Global Vaginitis Diagnostics market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Vaginitis Diagnostics market segment percentages, by Application, 2024 (%)
Hospitals
Specialty Clinics
Others
Global Vaginitis Diagnostics market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Vaginitis Diagnostics market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vaginitis Diagnostics revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Vaginitis Diagnostics revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Atrida
Becton, Dickinson and Company
Cepheid (Danaher Corporation)
F. Hoffmann-La Roche Ltd.
Hologic, Inc.
Laboratory Corporation of America Holdings
QIAGEN
Quest Diagnostics Incorporated
Quidel Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Vaginitis Diagnostics, market overview.
Chapter 2: Global Vaginitis Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Vaginitis Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vaginitis Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Vaginitis Diagnostics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Vaginitis Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Vaginitis Diagnostics Overall Market Size
2.1 Global Vaginitis Diagnostics Market Size: 2024 VS 2032
2.2 Global Vaginitis Diagnostics Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Vaginitis Diagnostics Players in Global Market
3.2 Top Global Vaginitis Diagnostics Companies Ranked by Revenue
3.3 Global Vaginitis Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Vaginitis Diagnostics Companies in Global Market, by Revenue in 2024
3.5 Global Companies Vaginitis Diagnostics Product Type
3.6 Tier 1, Tier 2, and Tier 3 Vaginitis Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Vaginitis Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Vaginitis Diagnostics Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Vaginitis Diagnostics Market Size Markets, 2024 & 2032
4.1.2 Nucleic Acid Amplification Assays
4.1.3 DNA Probe
4.1.4 Clinical Test
4.2 Segmentation by Type - Global Vaginitis Diagnostics Revenue & Forecasts
4.2.1 Segmentation by Type - Global Vaginitis Diagnostics Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Vaginitis Diagnostics Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Vaginitis Diagnostics Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Vaginitis Diagnostics Market Size, 2024 & 2032
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.1.4 Others
5.2 Segmentation by Application - Global Vaginitis Diagnostics Revenue & Forecasts
5.2.1 Segmentation by Application - Global Vaginitis Diagnostics Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Vaginitis Diagnostics Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Vaginitis Diagnostics Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Vaginitis Diagnostics Market Size, 2024 & 2032
6.2 By Region - Global Vaginitis Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Vaginitis Diagnostics Revenue, 2020-2025
6.2.2 By Region - Global Vaginitis Diagnostics Revenue, 2026-2032
6.2.3 By Region - Global Vaginitis Diagnostics Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Vaginitis Diagnostics Revenue, 2020-2032
6.3.2 United States Vaginitis Diagnostics Market Size, 2020-2032
6.3.3 Canada Vaginitis Diagnostics Market Size, 2020-2032
6.3.4 Mexico Vaginitis Diagnostics Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Vaginitis Diagnostics Revenue, 2020-2032
6.4.2 Germany Vaginitis Diagnostics Market Size, 2020-2032
6.4.3 France Vaginitis Diagnostics Market Size, 2020-2032
6.4.4 U.K. Vaginitis Diagnostics Market Size, 2020-2032
6.4.5 Italy Vaginitis Diagnostics Market Size, 2020-2032
6.4.6 Russia Vaginitis Diagnostics Market Size, 2020-2032
6.4.7 Nordic Countries Vaginitis Diagnostics Market Size, 2020-2032
6.4.8 Benelux Vaginitis Diagnostics Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Vaginitis Diagnostics Revenue, 2020-2032
6.5.2 China Vaginitis Diagnostics Market Size, 2020-2032
6.5.3 Japan Vaginitis Diagnostics Market Size, 2020-2032
6.5.4 South Korea Vaginitis Diagnostics Market Size, 2020-2032
6.5.5 Southeast Asia Vaginitis Diagnostics Market Size, 2020-2032
6.5.6 India Vaginitis Diagnostics Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Vaginitis Diagnostics Revenue, 2020-2032
6.6.2 Brazil Vaginitis Diagnostics Market Size, 2020-2032
6.6.3 Argentina Vaginitis Diagnostics Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Vaginitis Diagnostics Revenue, 2020-2032
6.7.2 Turkey Vaginitis Diagnostics Market Size, 2020-2032
6.7.3 Israel Vaginitis Diagnostics Market Size, 2020-2032
6.7.4 Saudi Arabia Vaginitis Diagnostics Market Size, 2020-2032
6.7.5 UAE Vaginitis Diagnostics Market Size, 2020-2032
7 Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Vaginitis Diagnostics Major Product Offerings
7.1.4 Abbott Laboratories Vaginitis Diagnostics Revenue in Global Market (2020-2025)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Atrida
7.2.1 Atrida Corporate Summary
7.2.2 Atrida Business Overview
7.2.3 Atrida Vaginitis Diagnostics Major Product Offerings
7.2.4 Atrida Vaginitis Diagnostics Revenue in Global Market (2020-2025)
7.2.5 Atrida Key News & Latest Developments
7.3 Becton, Dickinson and Company
7.3.1 Becton, Dickinson and Company Corporate Summary
7.3.2 Becton, Dickinson and Company Business Overview
7.3.3 Becton, Dickinson and Company Vaginitis Diagnostics Major Product Offerings
7.3.4 Becton, Dickinson and Company Vaginitis Diagnostics Revenue in Global Market (2020-2025)
7.3.5 Becton, Dickinson and Company Key News & Latest Developments
7.4 Cepheid (Danaher Corporation)
7.4.1 Cepheid (Danaher Corporation) Corporate Summary
7.4.2 Cepheid (Danaher Corporation) Business Overview
7.4.3 Cepheid (Danaher Corporation) Vaginitis Diagnostics Major Product Offerings
7.4.4 Cepheid (Danaher Corporation) Vaginitis Diagnostics Revenue in Global Market (2020-2025)
7.4.5 Cepheid (Danaher Corporation) Key News & Latest Developments
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Corporate Summary
7.5.2 F. Hoffmann-La Roche Ltd. Business Overview
7.5.3 F. Hoffmann-La Roche Ltd. Vaginitis Diagnostics Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd. Vaginitis Diagnostics Revenue in Global Market (2020-2025)
7.5.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.6 Hologic, Inc.
7.6.1 Hologic, Inc. Corporate Summary
7.6.2 Hologic, Inc. Business Overview
7.6.3 Hologic, Inc. Vaginitis Diagnostics Major Product Offerings
7.6.4 Hologic, Inc. Vaginitis Diagnostics Revenue in Global Market (2020-2025)
7.6.5 Hologic, Inc. Key News & Latest Developments
7.7 Laboratory Corporation of America Holdings
7.7.1 Laboratory Corporation of America Holdings Corporate Summary
7.7.2 Laboratory Corporation of America Holdings Business Overview
7.7.3 Laboratory Corporation of America Holdings Vaginitis Diagnostics Major Product Offerings
7.7.4 Laboratory Corporation of America Holdings Vaginitis Diagnostics Revenue in Global Market (2020-2025)
7.7.5 Laboratory Corporation of America Holdings Key News & Latest Developments
7.8 QIAGEN
7.8.1 QIAGEN Corporate Summary
7.8.2 QIAGEN Business Overview
7.8.3 QIAGEN Vaginitis Diagnostics Major Product Offerings
7.8.4 QIAGEN Vaginitis Diagnostics Revenue in Global Market (2020-2025)
7.8.5 QIAGEN Key News & Latest Developments
7.9 Quest Diagnostics Incorporated
7.9.1 Quest Diagnostics Incorporated Corporate Summary
7.9.2 Quest Diagnostics Incorporated Business Overview
7.9.3 Quest Diagnostics Incorporated Vaginitis Diagnostics Major Product Offerings
7.9.4 Quest Diagnostics Incorporated Vaginitis Diagnostics Revenue in Global Market (2020-2025)
7.9.5 Quest Diagnostics Incorporated Key News & Latest Developments
7.10 Quidel Corporation
7.10.1 Quidel Corporation Corporate Summary
7.10.2 Quidel Corporation Business Overview
7.10.3 Quidel Corporation Vaginitis Diagnostics Major Product Offerings
7.10.4 Quidel Corporation Vaginitis Diagnostics Revenue in Global Market (2020-2025)
7.10.5 Quidel Corporation Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Vaginitis Diagnostics Market Opportunities & Trends in Global Market
Table 2. Vaginitis Diagnostics Market Drivers in Global Market
Table 3. Vaginitis Diagnostics Market Restraints in Global Market
Table 4. Key Players of Vaginitis Diagnostics in Global Market
Table 5. Top Vaginitis Diagnostics Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Vaginitis Diagnostics Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Vaginitis Diagnostics Revenue Share by Companies, 2020-2025
Table 8. Global Companies Vaginitis Diagnostics Product Type
Table 9. List of Global Tier 1 Vaginitis Diagnostics Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vaginitis Diagnostics Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type – Global Vaginitis Diagnostics Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Vaginitis Diagnostics Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Vaginitis Diagnostics Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application– Global Vaginitis Diagnostics Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Vaginitis Diagnostics Revenue, (US$, Mn), 2026-2032
Table 17. By Region– Global Vaginitis Diagnostics Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Vaginitis Diagnostics Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Vaginitis Diagnostics Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Vaginitis Diagnostics Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Vaginitis Diagnostics Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Vaginitis Diagnostics Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Vaginitis Diagnostics Revenue, (US$, Mn), 2026-2032
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Vaginitis Diagnostics Product Offerings
Table 32. Abbott Laboratories Vaginitis Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Atrida Corporate Summary
Table 35. Atrida Vaginitis Diagnostics Product Offerings
Table 36. Atrida Vaginitis Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 37. Atrida Key News & Latest Developments
Table 38. Becton, Dickinson and Company Corporate Summary
Table 39. Becton, Dickinson and Company Vaginitis Diagnostics Product Offerings
Table 40. Becton, Dickinson and Company Vaginitis Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 41. Becton, Dickinson and Company Key News & Latest Developments
Table 42. Cepheid (Danaher Corporation) Corporate Summary
Table 43. Cepheid (Danaher Corporation) Vaginitis Diagnostics Product Offerings
Table 44. Cepheid (Danaher Corporation) Vaginitis Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 45. Cepheid (Danaher Corporation) Key News & Latest Developments
Table 46. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 47. F. Hoffmann-La Roche Ltd. Vaginitis Diagnostics Product Offerings
Table 48. F. Hoffmann-La Roche Ltd. Vaginitis Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 49. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 50. Hologic, Inc. Corporate Summary
Table 51. Hologic, Inc. Vaginitis Diagnostics Product Offerings
Table 52. Hologic, Inc. Vaginitis Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 53. Hologic, Inc. Key News & Latest Developments
Table 54. Laboratory Corporation of America Holdings Corporate Summary
Table 55. Laboratory Corporation of America Holdings Vaginitis Diagnostics Product Offerings
Table 56. Laboratory Corporation of America Holdings Vaginitis Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 57. Laboratory Corporation of America Holdings Key News & Latest Developments
Table 58. QIAGEN Corporate Summary
Table 59. QIAGEN Vaginitis Diagnostics Product Offerings
Table 60. QIAGEN Vaginitis Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 61. QIAGEN Key News & Latest Developments
Table 62. Quest Diagnostics Incorporated Corporate Summary
Table 63. Quest Diagnostics Incorporated Vaginitis Diagnostics Product Offerings
Table 64. Quest Diagnostics Incorporated Vaginitis Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 65. Quest Diagnostics Incorporated Key News & Latest Developments
Table 66. Quidel Corporation Corporate Summary
Table 67. Quidel Corporation Vaginitis Diagnostics Product Offerings
Table 68. Quidel Corporation Vaginitis Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 69. Quidel Corporation Key News & Latest Developments
List of Figures
Figure 1. Vaginitis Diagnostics Product Picture
Figure 2. Vaginitis Diagnostics Segment by Type in 2024
Figure 3. Vaginitis Diagnostics Segment by Application in 2024
Figure 4. Global Vaginitis Diagnostics Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Vaginitis Diagnostics Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Vaginitis Diagnostics Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Vaginitis Diagnostics Revenue in 2024
Figure 9. Segmentation by Type – Global Vaginitis Diagnostics Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Vaginitis Diagnostics Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application – Global Vaginitis Diagnostics Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Vaginitis Diagnostics Revenue Market Share, 2020-2032
Figure 13. By Region - Global Vaginitis Diagnostics Revenue Market Share, 2020-2032
Figure 14. By Country - North America Vaginitis Diagnostics Revenue Market Share, 2020-2032
Figure 15. United States Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Vaginitis Diagnostics Revenue Market Share, 2020-2032
Figure 19. Germany Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 20. France Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Vaginitis Diagnostics Revenue Market Share, 2020-2032
Figure 27. China Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 31. India Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Vaginitis Diagnostics Revenue Market Share, 2020-2032
Figure 33. Brazil Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Vaginitis Diagnostics Revenue Market Share, 2020-2032
Figure 36. Turkey Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Vaginitis Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 40. Abbott Laboratories Vaginitis Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Atrida Vaginitis Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Becton, Dickinson and Company Vaginitis Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Cepheid (Danaher Corporation) Vaginitis Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. F. Hoffmann-La Roche Ltd. Vaginitis Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Hologic, Inc. Vaginitis Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Laboratory Corporation of America Holdings Vaginitis Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. QIAGEN Vaginitis Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Quest Diagnostics Incorporated Vaginitis Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Quidel Corporation Vaginitis Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
